Insider Transactions in Q2 2019 at Odonate Therapeutics, Inc. (ODTC)
Insider Transaction List (Q2 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 26
2019
|
Tang Kevin C Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
769,231
+5.18%
|
$20,000,006
$26.0 P/Share
|
|
Jun 26
2019
|
Boxer Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
384,615
+10.26%
|
$9,999,990
$26.0 P/Share
|
|
Jun 18
2019
|
Tang Kevin C Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
21,350
+0.16%
|
$555,100
$26.89 P/Share
|
|
Jun 17
2019
|
Tang Kevin C Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
10,042
+0.04%
|
$261,092
$26.58 P/Share
|
|
Jun 14
2019
|
Tang Kevin C Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
18,608
+0.14%
|
$446,592
$24.95 P/Share
|
|
Jun 07
2019
|
Tang Kevin C Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
20,000
+0.15%
|
$520,000
$26.31 P/Share
|
|
Jun 06
2019
|
Tang Kevin C Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
56,308
+0.14%
|
$1,520,316
$27.74 P/Share
|
|
Jun 05
2019
|
Tang Kevin C Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
39,456
+0.15%
|
$986,400
$25.63 P/Share
|
|
Jun 04
2019
|
Tang Kevin C Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
38,950
+0.15%
|
$934,800
$24.96 P/Share
|
|
Jun 03
2019
|
Tang Kevin C Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
15,286
+0.06%
|
$336,292
$22.51 P/Share
|